Japanese Regulators Have Approved AstraZeneca Lung Cancer Drug
AstraZeneca announced Tuesday that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Tagrisso (osimertinib) for the 1st-line treatment of patients with inoperable or recurrent epidermal growth factor …
Japanese Regulators Have Approved AstraZeneca Lung Cancer Drug Read More